Seno Medical Instruments receives CE Mark for Imagio® breast imaging system
SAN ANTONIO, TEXAS – April 10, 2014 – Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced today that it has received the CE Mark for Imagio®, a new opto-acoustic imaging system, in Europe. Seno is in the middle of […]
Data Show Seno Medical Instruments’ Imagio™ Could Potentially Allow Doctors to Eliminate the Need for a Breast Biopsy and Monitor Early Response to Treatment
VIENNA, AUSTRIA – March 10, 2014 – Seno Medical Instruments, Inc., the company pioneering development of opto-acoustic (OA) imaging as a tool to improve the process of diagnosing breast cancer, today announced that two analyses of outcomes from a U.S. Feasibility Study of its investigational Imagio™ breast imaging device were presented at the annual meeting of […]
Seno Medical Instruments Raising $39 Million in Series C Funding Round
SAN ANTONIO, TEXAS – February 25, 2014 – Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the process of diagnosing breast cancer, today announced that it has sold $34.6 million of a $39 million Series C equity funding round from existing investors with the lead investment from MedCare Investment Funds. […]
Preliminary Data Show Seno Medical Instruments’ Imagio™ Could Potentially Allow Doctors to Rule Out the Need for a Breast Biopsy
SAN ANTONIO, TEXAS – December 17, 2013 – Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the process of diagnosing breast cancer, today announced new statistical analysis of outcomes from a Feasibility Study of its investigational Imagio™ breast imaging device. The analysis of data from the Feasibility Study, presented at […]
New Data Show Seno Medical Instruments’ Imagio™ May Help Reduce Negative Biopsies for Breast Cancer
CHICAGO, ILLINOIS – December 4, 2013 – Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the process of diagnosing breast cancer, today announced preliminary information from a feasibility study of its Imagio™ breast imaging device. Results from the feasibility study suggest that information from Imagio, beyond that available from traditional […]
Seno Medical Instruments, Inc. Launches Pivotal Study of New Functional Imaging Platform in Breast Cancer Diagnosis
SAN ANTONIO, TEXAS – November 25, 2013 – Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the diagnosis of cancer, announced today that the first 100 patients have been enrolled into its Pivotal Study of Imagio™, a new opto-acoustic imaging system that may help women with benign breast masses avoid […]
Seno Medical Instruments, Inc. CEO Janet Campbell Wins Gold Stevie® Award in 2013 Stevie Awards for Women in Business
SAN ANTONIO, TEXAS – November 21, 2013 – Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the diagnosis of cancer, today announced that CEO Janet Campbell has been named the winner of a Gold Stevie® Award for Female Entrepreneur of the Year in the 10th annual Stevie Awards for […]
Seno Medical Instruments Launches First-Ever Commercially Available Opto-Acoustic Small Animal Imaging Research System
SAN ANTONIO, TEXAS — July 1, 2008 – Seno Medical Instruments, Inc., of Texas, The University of Prince Edward Island, and Ryerson University of Toronto, officially celebrated the formation of an exciting research partnership that has great potential to benefit human and animal health at a public ceremony held June 25, 2008 at Prince Edward Island. Clinical Model of Novel […]
Dr. Thomas F. Budinger Joins SENO Medical Instruments
SAN ANTONIO, TEXAS — June 18, 2008 – Seno Medical Instruments, Inc., a San Antonio company engaged in the development of opto-acoustics, the next generation cancer imaging technology, today announced the appointment of Thomas F. Budinger, M.D. to the company’s Scientific Advisory Committee. “Tom’s participation as a member of Seno’s Scientific Advisory Committee will greatly enhance Seno’s knowledge of other […]
Dr. William F. Keane Named Chief Medical Officer at SENO Medical Instruments
SAN ANTONIO, TEXAS – May 13, 2008 – Seno Medical Instruments, Inc., today announced the appointment of William F. Keane, M.D. as its Chief Medical Officer. San Antonio, TX – SENO Medical Instruments, Inc. a San Antonio company engaged in the development of a next-generation, opto-acoustic cancer platform technology, today announced the appointment of William […]